titlesubtitle

superslotscasino| Yingtong Technology-B intraday changes are approaching noon, and a sharp rise of 5.10%

editor|
77

April 29, 2024, near 11:49 at noonSuperslotscasino, Eagle pupil Technology-B (02251)Superslotscasino.HK) the stock fluctuated, with the share price rising sharply by 5.10%. As of press time, the stock was reported at 16.040 Hong Kong dollars per share, with a turnover of 58300 shares, a turnover rate of 0.11% and an amplitude of 4.72%.

superslotscasino| Yingtong Technology-B intraday changes are approaching noon, and a sharp rise of 5.10%

On the capital side, the stock has an inflow of HK $636462 and an outflow of HK $157472.

The most recent results show that the stock achieved operating income of HK $225 million, net profit of-HK $146 million, earnings per share of HK $1.41, gross profit of HK $138 million and price-earnings ratio of-11.36 times.

In terms of institutional ratings, 100% of the two agencies involved in the rating gave buy advice, while no brokerage gave hold or sell advice.

Eagle pupil Technology-B shares in the medical equipment and supplies industry, the overall increase of 0.29%. Among its related stocks, minimally invasive robot-B, minimally invasive medical care, and Kangyi biology-B rose significantly, while the related stocks with larger amplitudes were minimally invasive robot-B, Kaisa Health, and Ziyuan, with amplitudes of 14.14%, 13.04% and 12.73%, respectively.

Eagle pupil Technology-B Company profile: Beijing Eagle pupil Science and Technology Development Co., Ltd. is a Chinese company. The company's main business is to provide early retinal detection, diagnosis and health risk assessment solutions based on artificial intelligence. The company's main product is Airdoc-AIFUNDUS 1.0. The company's products can be used in the diagnosis of glaucoma, cataracts, ICVD and ASCVD, gestational diabetic retinopathy, gestational hypertension retinopathy, etc. In addition, the company has developed a range of other medical device software (SaMD) and health risk assessment solutions to meet the various health care needs of the entire population, including hospitals, community clinics, health check-up centers and insurance companies.

(the above content is Portfolio based on public information, intelligently generated by programs or algorithms, only as a reference for users to view the market, not as investment advice or transaction basis. The stock market is risky, please make a careful decision. )